Acutaas Chemicals Share News - Latest Updates, Live News & More

Latest news about Acutaas Chemicals

Acutaas Chemicals Raises Revenue Growth Forecast from 25% to 30% 2 hrs ago Today

Acutaas Chemicals has revised its revenue growth forecast upward from 25% to approximately 30%, representing a 5 percentage point increase. This positive adjustment reflects improved business momentum, stronger market conditions, and management's increased confidence in the company's operational performance and market positioning.

Acutaas Chemicals Reports Strong Q3 Performance with Net Profit Rising to ₹1.1 Billion 2 hrs ago Today

Acutaas Chemicals Limited Receives Relief as GST Demand of Rs. 15.44 Lakhs Dropped by Appeals Authority 22 hrs ago Yesterday

AcutaaS Chemicals Inaugurates Phase 1 Manufacturing Block with 30% Revenue Boost 9 days ago

Acutaas Chemicals Secures Credit Rating Reaffirmation with Enhanced Bank Facilities Dec 04, 2025

More news about Acutaas Chemicals

24Oct 25

Acutaas Chemicals Reports Robust Q2 FY26 Results with 24% Revenue Growth and Margin Expansion

Acutaas Chemicals Limited reported robust Q2 FY26 results with revenue up 24.10% to INR 306.20 crores. EBITDA doubled to INR 95.30 crores, and PAT increased 91.30% to INR 71.90 crores. The Advanced Pharmaceutical Intermediates segment grew 27.10%, while Specialty Chemicals rose 7.30%. H1 FY26 saw total revenue increase 21.30% to INR 513.40 crores. The company plans a INR 180 crore capex for its Electrolyte Additives Project and INR 30 crores for a Pilot Plant. Acutaas revised its FY26 EBITDA margin guidance to 28-30% and maintains a 25% revenue growth target.

20Oct 25

Acutass Chemicals Projects 25% Revenue Growth for FY26, Raises EBITDA Margin Guidance

Acutass Chemicals has announced ambitious growth projections for FY26. The company expects a 25% increase in revenue and an EBITDA margin of 28-30%. Their specialty chemicals business is projected to grow by 10-15%. The working capital cycle is estimated to be between 95-105 days. These projections reflect the company's confidence in its business strategy and market positioning in the specialty chemicals sector.

17Oct 25

AcutaaS Chemicals Reports Strong Q2 FY26 Results, MD Confident of 25% Annual Revenue Growth

Acutaas Chemicals Limited reported robust Q2 FY26 results with revenue up 24.1% YoY to ₹306.20 crores, EBITDA up 94.8% to ₹95.30 crores, and PAT up 91.3% to ₹71.90 crores. The Advanced Pharmaceutical Intermediates segment grew by 27.4% YoY, while Specialty Chemicals grew by 7.3%. The company is expanding into Battery Chemicals and Semiconductors. Management remains confident of achieving approximately 25% revenue growth for the full year.

17Oct 25

Acutaas Chemicals Reports Robust Q2 FY26 Results: Revenue Surges 25.7%, Net Profit Nearly Doubles

Acutaas Chemicals Limited reported impressive Q2 FY26 results. Revenue increased by 25.70% to ₹3,061.90 crore. Net profit surged 93.60% to ₹730.00 crore. EBITDA grew 100.80% to ₹966.00 crore, with the EBITDA margin expanding to 31.55%. The company's performance demonstrates strong growth across key financial metrics, reflecting its robust market position and operational efficiency in the specialty chemicals sector.

25Sept 25

ACUTAAS Chemicals Shareholders Approve Key Leadership Reappointments and Financial Statements

Acutaas Chemicals Limited held its 18th Annual General Meeting on September 25, 2025. Shareholders approved the reappointment of Nareshkumar Ramjibhai Patel as Managing Director and Executive Chairman, along with two Whole Time Directors for five-year terms. Two independent directors were also reappointed. The meeting adopted financial statements for FY 2024-25 and declared a final dividend of 30% (₹1.50 per equity share). Shareholders ratified cost auditors' remuneration and appointed new Secretarial Auditors.

27Aug 25

Acutaas Chemicals Achieves Platinum Medal from EcoVadis, Ranking in Top 1% for Global Sustainability

Acutaas Chemicals Limited has achieved a Platinum Medal accreditation from EcoVadis, placing it among the top 1% of companies globally for sustainability performance. This upgrade from their previous Gold Medal rating was announced on August 26, 2025. EcoVadis assesses companies on environmental practices, labor and human rights, ethics, and sustainable procurement. The achievement is particularly significant for Acutaas Chemicals as a player in the chemical sector, potentially enhancing its reputation among environmentally conscious stakeholders.

30Jul 25

Acutaas Chemicals Grants 3.25L Stock Options, Elevates Abhishek Patel to Senior Role

Acutaas Chemicals has granted 3,25,009 employee stock options under ESOS 2023 at Rs. 305 per option, featuring a 4-year vesting schedule with both time-based and performance-based components. The company also elevated Abhishek Patel to Senior Management Person and reported strong Q1 FY2026 results with 17.3% revenue growth and 199.6% PAT increase.

30Jul 25

Acutaas Chemicals Reports Strong Q1 Results with 17.3% Revenue Growth

Acutaas Chemicals Limited announced robust Q1 FY24 results with revenue up 17.3% YoY to ₹2,072.00 crore and net profit soaring 199.6% to ₹440.00 crore. EBITDA margin expanded by 785 basis points to 24.6%. The company's growth was driven by strong performance in Pharmaceutical Intermediates. Acutaas entered a joint venture in South Korea, strengthening its position in semiconductor markets. The company also invested in its subsidiary AAML and fully utilized the ₹99.10 crore raised through a preferential issue.

30Jul 25

Acutaas Chemicals Reports Strong Q1 FY26 Performance with 17.3% Revenue Growth

Acutaas Chemicals announced robust Q1 FY26 results with revenue up 17.3% to ₹2,072.00 crore and net profit soaring 199.6% to ₹440.00 crore. EBITDA margin expanded by 785 basis points to 24.6%. The company's Pharmaceutical Intermediates business drove growth, and both pharma facilities received PMDA GMP certification. A new joint venture in South Korea aims to strengthen its semiconductor market position. Acutaas fully utilized ₹99.10 crore from a preferential issue for capital expenditure and corporate purposes. The company projects 25% growth with improved margins for FY26.

30Jul 25

ACUTAAS Chemicals Reports Strong Q1 FY26 Results, MD Targets 25% Growth for FY26

ACUTAAS Chemicals Limited reported robust Q1 FY26 financial results with significant growth across key metrics. Revenue from operations increased by 17.3% to ₹2,072.00 crore, EBITDA grew by 72.4% to ₹509.00 crore, and net profit surged by 199.6% to ₹440.00 crore. The company's pharmaceutical intermediates business was the primary growth driver. Both pharmaceutical facilities received PMDA GMP certification. ACUTAAS entered a joint venture in South Korea to strengthen its position in the semiconductor market. The company's Managing Director expressed confidence in achieving 25% growth with improved margins for FY26.

30Jul 25

Acutaas Chemicals Reports Robust Q1 FY2026 Results with 72% EBITDA Growth

Acutaas Chemicals Limited announced impressive Q1 FY2026 results. Revenue from operations increased by 21% to ₹2,072.37 crore. EBITDA surged 72% to ₹509.00 crore, with margin expanding to 24.56%. Profit after tax grew by 199% to ₹440.11 crore. The company, formerly known as Ami Organics Limited, changed its name effective May 15, 2025. Two wholly-owned subsidiaries also underwent name changes. The Board of Directors approved these unaudited financial results on July 30, 2025.

25Jul 25

Acutaas Chemicals to Host Q1FY26 Earnings Conference Call on July 30

Acutaas Chemicals Limited (formerly AMI Organics) will host an earnings call on July 30, 2025, at 4:30 PM IST to discuss Q1FY26 financial results. Key executives participating include Naresh Patel (CMD), Abhishek Patel (VP Strategy), and Bhavin Shah (CFO). The call follows a board meeting to approve results. Universal and international toll-free dial-in numbers are provided. The trading window for designated persons will be closed from July 1, 2025, until 48 hours after results declaration.

23Jul 25

Acutaas Chemicals Invests Rs 49.99 Crores in Subsidiary, Eyes Semiconductor Specialty Chemicals Expansion

Acutaas Chemicals Limited has invested Rs 49.99 crores in its wholly-owned subsidiary, Acutaas Advance Material Limited (AAML), through a rights issue. The investment involves subscribing to 30,48,780 equity shares at Rs 164.00 per share. This is part of a larger plan to invest up to Rs 150.00 crores in AAML through loans and equity subscriptions. AAML, incorporated in September 2023, specializes in semiconductor specialty chemicals and has operations in India and South Korea. The investment aims to expand Acutaas Chemicals' presence in the growing semiconductor specialty chemicals market.

30Jun 25

Acutaas Chemicals' Subsidiary Forms Joint Venture in South Korea for Semiconductor Chemicals

Acutaas Chemicals' subsidiary Baml has entered into a joint venture agreement with South Korean company J & Materials. The venture will focus on manufacturing and selling specialty chemicals for the semiconductor industry, primarily in South Korea with plans for expansion. Baml is investing 30 billion Korean Won in the joint venture. The partnership aims to strengthen Acutaas Chemicals' position in the semiconductor industry and expand its market presence in South Korea.

27Jun 25

Acutaas Chemicals Enters Joint Venture for Semiconductor Specialty Chemicals in South Korea

Acutaas Chemicals has entered into a joint venture with J & Materials to create and market specialty chemicals for the semiconductor industry. The venture, with an investment of KRW 30 billion (₹190.00 crore), will initially focus on the South Korean market with plans for future expansion. This strategic move aims to capitalize on the growing demand for advanced chemicals in the semiconductor sector.

02May 25

AMI Organics Reports Strong FY25 Results, Anticipates 25% Revenue Growth in FY26

AMI Organics Limited reported robust financial results for FY25, with revenue crossing ₹1,000 crore, up 40.30% YoY. EBITDA increased by 80.60% to ₹232.00 crore, and PAT nearly doubled to ₹160.00 crore. The company announced a final dividend of ₹1.50 per share. AMI Organics plans to rebrand as Acutaas Chemicals Limited and targets 25% revenue growth in FY26. The company raised funds through preferential issue and QIP for expansion and is focusing on R&D, including development of electrolyte additives.

02May 25

AMI Organics Reports Robust Q4 and FY2025 Financial Performance, Declares Dividend, and Projects Strong FY26 Growth

AMI Organics Limited has reported significant growth in Q4 and FY2025. Q4 revenue increased by 37% to ₹308.50 crore, EBITDA grew 97% to ₹84.10 crore, and net profit doubled to ₹53.00 crore. FY2025 revenue exceeded ₹1000 crore, marking 45%+ growth. The company announced a final dividend of ₹1.50 per share and plans to change its name to Acutaas Chemicals Limited. A 25% revenue growth is projected for FY2026.